Updates from the RegMedNet team on the network.
Seeking to cure the incurable - Canada and Japan setting the world pace for innovations in regenerative medicine
National Post article highlights the important role the Centre for Commercialization of Regenerative Medicine (CCRM) is taking to help Canadian cell therapy companies like RepliCel Life Sciences (TSX.V: RP) create pathways for commercialization in Canada and Japan.
Take the RegMedNet survey and get free journal access to the Future Science Group journal of your choice!
RegMedNet is conducting a short survey to find out how we can provide the best possible service to our online users.